An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Mirion, a global provider of radiation detection solutions, announced the redemption of all publicly traded warrants to purchase shares of Class A common stock at a redemption price of $0.10 per warrant. The redemption date is set for May 20, 2024, with the stock price condition already met. Warrant holders can exercise their warrants until the redemption date, either for cash or on a cashless basis. The redemption process and contact information for inquiries are provided in the press release.
Mirion, un fornitore globale di soluzioni per la rilevazione delle radiazioni, ha annunciato il riscatto di tutte le warrant quotate in borsa per l'acquisto di azioni di Classe A al prezzo di $0.10 per warrant. La data di riscatto è fissata per il 20 maggio 2024, con la condizione del prezzo delle azioni già soddisfatta. I detentori di warrant possono esercitare i loro diritti fino alla data di riscatto, sia in contanti sia su base non monetaria. Il processo di riscatto e le informazioni di contatto per le richieste sono forniti nel comunicato stampa.
Mirion, un proveedor global de soluciones de detección de radiación, anunció el canje de todas las warrants públicamente negociadas para comprar acciones de la Clase A común a un precio de $0.10 por warrant. La fecha de canje está fijada para el 20 de mayo de 2024, habiéndose ya cumplido la condición del precio de la acción. Los tenedores de warrants pueden ejercer sus derechos hasta la fecha de canje, ya sea en efectivo o mediante un proceso sin efectivo. El procedimiento de canje y la información de contacto para consultas se proporcionan en el comunicado de prensa.
방사선 탐지 솔루션을 제공하는 글로벌 기업 미리온이 클래스 A 보통주를 구매할 수 있는 모든 공개 거래 워런트를 워런트당 $0.10의 가격으로 상환한다고 발표했습니다. 상환 날짜는 2024년 5월 20일로 설정되었으며, 주식 가격 조건은 이미 충족되었습니다. 워런트 소유자는 상환 날짜까지 현금 또는 현금 없는 기준으로 워런트를 행사할 수 있습니다. 상환 절차와 문의를 위한 연락처 정보는 보도자료에서 제공됩니다.
Mirion, un fournisseur mondial de solutions de détection de radiation, a annoncé le rachat de tous les bons de souscription cotés en bourse pour l'achat d'actions ordinaires de Classe A à un prix de rachat de 0,10 $ par bon. La date de rachat est fixée au 20 mai 2024, la condition du prix de l'action ayant déjà été remplie. Les détenteurs de bons peuvent exercer leurs droits jusqu'à la date de rachat, soit en espèces, soit sur une base non monétaire. Le processus de rachat et les informations de contact pour les demandes de renseignements sont fournis dans le communiqué de presse.
Mirion, ein weltweiter Anbieter von Lösungen zur Strahlungsdetektion, hat die Einlösung aller öffentlich gehandelten Optionsscheine zum Kauf von Class A-Stammaktien zu einem Einlösungspreis von $0,10 pro Optionsschein bekanntgegeben. Das Einlösungsdatum ist für den 20. Mai 2024 festgesetzt, wobei die Bedingung des Aktienpreises bereits erfüllt ist. Inhaber der Optionsscheine können ihre Rechte bis zum Einlösungsdatum ausüben, entweder bar oder auf bargeldloser Basis. Der Einlösungsprozess und Kontaktinformationen für Anfragen sind in der Pressemitteilung bereitgestellt.
Positive
None.
Negative
None.
ATLANTA--(BUSINESS WIRE)--
Mirion ("we" or the "Company") (NYSE: MIR, MIR.WS), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced that it will redeem all of its publicly traded warrants to purchase shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), that remain outstanding at 5:00 pm New York City time on Monday, May 20, 2024 (the “Redemption Date”), for a redemption price of $0.10 per warrant (the “Redemption Price”).
Mirion has directed its warrant agent, Continental Stock Transfer & Trust Company (the “Warrant Agent”) or its authorized information agent, to deliver a notice of redemption (the “Notice of Redemption”) to the registered holders of outstanding warrants pursuant to the Warrant Agreement, dated as of June 29, 2020 (the “Warrant Agreement”), by and between Mirion (f/k/a GS Acquisition Holdings Corp II) and the Warrant Agent. Under the Warrant Agreement, Mirion is entitled to redeem its public warrants at a redemption price of $0.10 per warrant if the last sale price of the Common Stock equals or exceeds $10.00 per share on the trading day before the Company issues the notice of redemption (the “Stock Price Condition”), among other conditions.
The stock price condition was satisfied on April 17, 2024, the day before the Notice of Redemption is being sent to warrant holders. Warrants to purchase Common Stock that were issued under the Warrant Agreement in a private placement simultaneously with Mirion’s (f/k/a GS Acquisition Holdings Corp II) initial public offering and still held by the initial holders thereof or their permitted transferees are not subject to the Notice of Redemption.
Exercise Procedures and Deadline for Warrant Exercise
Warrant holders may continue to exercise their warrants to purchase shares of Common Stock until immediately before 5:00 p.m. New York City time on the Redemption Date. Holders may exercise their warrants and receive Common Stock (i) in exchange for a payment in cash of the $11.50 per warrant exercise price, or (ii) on a “cashless” basis in which case the exercising holder will receive a number of shares of Common Stock determined under the Warrant Agreement based on the redemption date and the redemption fair market value, as determined in accordance with the Warrant Agreement. The “fair market value” is based on the average last price per share of Common Stock for the 10 trading days ending on the third trading day prior to the date on which the Notice of Redemption is sent. In accordance with the Warrant Agreement, exercising holders will receive 0.220 of a share of Common Stock for each Warrant surrendered for exercise. If a holder of warrants would, after taking into account all of such holders’ warrants exercised at one time, be entitled to receive a fractional interest in a share of Common Stock, the number of shares of Common Stock the holder is entitled to receive will be rounded down to the nearest whole number of shares.
Holders wishing to exercise their warrants should follow the procedures described in the Notice of Redemption and the Election to Purchase form included with the notice. Holders of warrants held in “street name” should immediately contact their brokers to determine exercise procedures. Since the act of exercising is voluntary, holders must instruct their brokers to submit the warrants for exercise.
Termination of Warrant Rights
The warrants are listed on the NYSE under the ticker symbol “MIR WS.” Any outstanding Mirion public warrants that remain unexercised at 5:00 p.m. New York City time on the Redemption Date will be void and no longer exercisable, except to receive the Redemption Price or as otherwise described in the Notice of Redemption.
How to Redeem
The shares of Common Stock underlying the public warrants have been registered by the Company under the Securities Act of 1933, as amended, and are covered by a registration statement filed on Form S-3, as amended, with, and declared effective by, the Securities and Exchange Commission (Registration No. 333-268445). Exercise of public warrants should be directed through the broker of the warrant holder. In addition to the broker, questions may also be directed to Morrow Sodali at (800) 662-5200 (for individuals) / (203) 658-9400 (for banks and brokerages) or at mir@info.morrowsodali.com. Or contact Continental Stock Transfer & Trust Company, One State Street, 30th Floor, New York, New York 10004, Attention: Compliance Department, Telephone Number (212) 509-4000.
Additional information can be found on Mirion’s Investor Relations website: https://ir.mirion.com/
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,700 people and operates in 12 countries. Learn more at mirion.com.
No Offer or Solicitation
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any Mirion securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate”, “expect”, “hope”, “intend”, “may”, “might”, “should”, “would”, “will”, “understand” and similar words are intended to identify forward looking statements. These forward-looking statements include, but are not limited to, statements regarding redemption of the warrants. Further information on risks, uncertainties and other factors that could affect our financial results are included in the filings we make with the Securities and Exchange Commission (the “SEC”) from time to time, including our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and other periodic reports filed or to be filed with the SEC.
You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
What is the redemption price set by Mirion for the publicly traded warrants?
Mirion has set the redemption price at $0.10 per warrant for the publicly traded warrants.
When is the redemption date for the warrants announced by Mirion?
The redemption date for the warrants announced by Mirion is set for May 20, 2024.
How can warrant holders exercise their warrants according to the press release?
Warrant holders can exercise their warrants until 5:00 p.m. New York City time on the Redemption Date either for cash at $11.50 per warrant or on a cashless basis as per the Warrant Agreement.
What is the stock price condition mentioned in the press release by Mirion?
The stock price condition mentioned in the press release by Mirion states that the last sale price of the Common Stock must equal or exceed $10.00 per share on the trading day before the Company issues the notice of redemption.
Where can additional information about the redemption process be found according to the press release?
Additional information about the redemption process can be found on Mirion's Investor Relations website: https://ir.mirion.com/
mirion technologies is a provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear power, medical, military and homeland security markets. for more than 50 years, mirion's customers have relied on our solutions to protect people, property and the environment from nuclear and radiological hazards. mirion has facilities in europe, asia, and north america and is headquartered in the san francisco bay area.
